We’ve all heard of antibiotic resistance. The same thing is happening with other causes of infections in humans: fungi, viruses and parasites. This is making thrush and other infections hard to treat.
Academic rigour, journalistic flair
Articles on Viral infections
Displaying 1 - 20 of 54 articles
Hepatitis C treatments are up to 95% effective when caught early.
The Marburg virus, a close cousin of Ebola, currently has no approved treatments or vaccines to protect against it.
Inflammation and damage to the olfactory system from shingles, COVID-19 and herpes infections may contribute to Alzheimer’s disease.
Using a Nobel Prize-winning technique called cryo-EM, researchers were able to identify potential areas on the hepatitis C virus that a vaccine could target.
Respiratory syncytial virus may be common, but it can lead to severe infection in some children.
Evidence is growing there are changes to your immune system that may put you at risk of other infectious diseases.
Phages, or viruses that infect bacteria, can lie dormant within chromosomes until they’re triggered to replicate and burst out of their hosts.
Coinfections with bacteria can make viral infections even deadlier. Researchers have identified a protein in immune cells that may play a role in fighting both types of pathogens.
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
This is not the first time that the monkeypox virus has spread beyond Africa, its continent of origin. But the current epidemic is unprecedented for a number of reasons.
The latest report from the WHO and Unicef found cases have increased nearly 80% worldwide.
Decreases in respiratory infections during the pandemic suggest there may be a continued role for the selective, non-mandated use of measures like masks and social distancing even post-COVID-19.
Rhinoviruses may play a critical role in controlling the spread of SARS-CoV-2 among the human population.
SARS-CoV-2 is much like a zombie virus. It interferes with normal sickness behavior and blocks pain, turning its victims into unsick spreaders of the virus.
Resistant bacteria aren’t the only risk posed by overprescribing antibiotics. A more immediate risk is side-effects and reactions, which a new review shows are surprisingly frequent and often severe.
This antibody protects patients from viruses, even while on immunosuppressant drugs.
Bats have been the reservoir for recent disease outbreaks, including SARS and the current COVID-19 pandemic. But it’s human activity that allows the virus to cross over.
The conspiracy theory that Covid-19 was created in a laboratory has been widely reported, yet there is no evidence to support it. Why such theories thrive can easily be explained, however.
Antimicrobial resistance is a public health and economic disaster waiting to happen. If we do not address this threat, by 2050 more people will die from drug-resistant infections than from cancer.
Top contributors
-
Biologiste, Immunologiste. Directeur de recherches au FNRS, Université Libre de Bruxelles (ULB)
-
Professor of Global Biosecurity, NHMRC Principal Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Laureate Professor, The Peter Doherty Institute for Infection and Immunity
-
Deputy Director, WHO Collaborating Centre for Reference and Research on Influenza
-
Professor and Director of Doherty Epidemiology, The University of Melbourne
-
Associate Professor, Computing & Information Systems; Director, Melbourne Data Analytics Platform, The University of Melbourne
-
Professor and Dean of Programs (Pharmacy and Biomedical Sciences), University of South Australia
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Professor, Australian National University
-
Chief Research Scientist, Virology Project Leader, CSIRO
-
Professor of Infectious Diseases, Monash University
-
Professor, Biomedicine Discovery Institute, Monash University
-
Brett Montgomery is a Friend of The Conversation.
Senior Lecturer in General Practice, The University of Western Australia
-
PhD Student in Immunology, Imperial College London
-
Research Fellow in Virology, University of Leeds
